BioNTech - Latest News, Analysis, Opinion

Latest Articles in BioNTech

BioNTech Begins Trials Of mRNA-based Malaria Vaccine

Scientists around the world have been working for decades to develop a vaccine to prevent malaria, which infects millions of people every year and leads to hundreds of thousands of deaths - most of them babies and young children in the poorest parts of Africa

Germany Sends First Batch Of BioNTech Vaccines To Covid Hit China

BW Online Bureau

Economy

The shipment comes after China agreed to allow German nationals in China to get the shot following a deal during Chancellor Olaf Scholz's visit in Beijing last month, with the German leader pressing for Beijing to allow the shot to be made freely available to Chinese citizens as well

Pfizer, BioNTech Omicron Booster Delivers Strong Response

BW Online Bureau

Economy

Omicron-tailored shots made by Pfizer and rival Moderna Inc have already been given the green light in the United States for adults as well as for children as young as five years

Pfizer, BioNTech Seek FDA Approval For New Covid Boosters For Kids

BW Online Bureau

Economy

The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11

Moderna Sues Pfizer & BioNTech For Patent Infringement Over mRNA Vaccine

BW Online Bureau

Economy

Moderna believes that Pfizer and BioNTech's COVID-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology. This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax

Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11

BW Online Bureau

Health

But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.

Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

BW Online Bureau

Health

The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs Up Expected

BW Online Bureau

Health

J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

Raj Kantak

World

Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand

Raj Kantak

World

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand

J&J Vaccine Adds To COVID-19 Armoury, Includes South African Variant

BW Online Bureau

Companies & Markets

J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine's effectiveness was below those of rivals. Moderna's stock gained 8% to $172.80.